Prospective, Randomized, Parallel-Controlled Study of Brain Computer Interface Integrated Robotic Mirror Therapy for Post-Stroke Upper Limb Motor Function Disorder
BCI-RMT
A Prospective, Randomized, Parallel-Controlled Clinical Study Protocol of Non-Invasive Brain Computer Interface Robot Based on Mirror Rehabilitation Theory in the Treatment of Upper Limb Motor Function Disorder After Stroke
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to utilize non-invasive brain-computer interface technology in conjunction with mirror therapy to design a new paradigm for rehabilitation robots to induce compensatory movements on the healthy side in stroke patients, evaluate the potential rehabilitation value of this paradigm for patients with severely impaired motor areas on the affected side, explore the neural rehabilitation compensation mechanism, and provide more personalized rehabilitation treatment strategies for patients with post-stroke motor dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2026
CompletedFirst Posted
Study publicly available on registry
April 28, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
April 28, 2026
April 1, 2026
1.6 years
April 22, 2026
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Fugl-Meyer Assessment of the Upper Extremity for the affected upper limb at the forth week after enrollment.
The primary outcome measure of this study was the Fugl-Meyer Assessment of the Upper Extremity (FMA-UE), which was employed to assess upper limb motor function in patients. The FMA-UE consists of 33 items, each graded on a 0-2 scale (0 = unable to perform, 1 = partially accomplished, 2 = fully accomplished), with a total score ranging from 0 to 66; higher scores indicate superior upper limb motor function. This scale enables comprehensive evaluation of joint range of motion, reflex activity, isolated motor control, and coordination in the hemiplegic upper extremity of stroke patients.
4 weeks
Secondary Outcomes (7)
The improvement in the Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) for the affected upper limb at the eighth week after enrollment.
8 weeks
Changes in neural conduction pathways at the forth week after enrollment.
4 weeks
Differences in changes of electroencephalographic (EEG) signals at the forth week after enrollment.
4 weeks
Improvements in the Wolf Motor Function Test of the affected upper extremity at the forth week and the eighth week after enrollment.
4 weeks and 8 weeks
Improvements in Modified Barthel Index (MBI) scores at the forth week and the eighth week after enrollment.
4 weeks and 8 weeks
- +2 more secondary outcomes
Study Arms (2)
Control group
NO INTERVENTIONThe control group received conventional comprehensive rehabilitation therapy for 30 minutes per session, twice daily, 5 days per week, for 4 consecutive weeks.This therapy combined techniques including Bobath, Brunnstrom, Motor Relearning Program (MRP), and Proprioceptive Neuromuscular Facilitation (PNF), and involved training of movements such as shoulder flexion, extension and abduction, elbow flexion and extension, forearm pronation and supination, wrist flexion and extension, flexion and extension of interphalangeal and metacarpophalangeal joints, finger-to-finger opposition and thumb opposition, as well as roller training, ball grasping training, sanding board training, wooden peg moving training and card flipping training.
Experimental Group
EXPERIMENTALThe experimental group received brain computer interface-robotic mirror therapy (BCI-RMT) 5 days per week for 4 consecutive weeks, combined with conventional comprehensive rehabilitation therapy at 30 minutes per session, twice daily, 5 days per week. Each BCI-RMT session included a basic phase and an intensive phase, with a total training duration of approximately 20 minutes. The intervention was implemented using a brain-computer interface intelligent exoskeleton active and passive training system (Model: AiHand Expanse-BCI-L1) developed by Shuli Zhixing (Xi'an) Intelligent Technology Co., Ltd., a subsidiary of Shanghai Shuli Intelligent Technology Co., Ltd. BCI-RMT was performed by acquiring electroencephalographic signals from the unaffected hemisphere via a brain-computer interface, analyzing the signals with artificial intelligence, and finally delivering assisted motor function rehabilitation for the affected upper extremity via an intelligent exoskeleton training robot.
Interventions
BCI-RMT was performed by acquiring electroencephalographic signals from the unaffected hemisphere via a brain-computer interface, analyzing the signals with artificial intelligence, and finally delivering assisted motor function rehabilitation for the affected upper extremity via an intelligent exoskeleton training robot.
Eligibility Criteria
You may qualify if:
- Aged 30 to 80 years
- Patients with unilateral upper limb motor dysfunction caused by primary ischemic/hemorrhagic stroke within 1 to 6 months prior to enrollment
- Cerebral magnetic resonance diffusion-weighted imaging (DWI) at the time of onset indicating that the stroke lesion is limited to the unilateral basal ganglia region
- Modified Rankin Scale (mRS) score of 0 to 2 before stroke onset
- Fugl-Meyer Motor Function Assessment of Upper Extremities (FMA-UE) score of 10 to 42
- Montreal Cognitive Assessment (MoCA) score \> 18
- Fugl-Meyer Balance Assessment score \> 6
- Normal binocular visual acuity or corrected visual acuity
- Normal hearing and intact verbal comprehension ability
- Provided written informed consent
You may not qualify if:
- Patients with other severe cardiovascular and cerebrovascular diseases and unstable vital signs
- Patients with motor dysfunction caused by other etiologies, such as amyotrophic lateral sclerosis, myasthenia gravis, muscular dystrophy, hypokalemic periodic paralysis, spondylitis, arthritis, osteomyelitis, etc.
- Patients with severe diseases of the lungs, liver, kidneys and other vital organs
- Patients with limb movement impairment caused by diseases such as fractures and arthritis
- Modified Ashworth Scale (MAS) score \> 3
- Patients unable to understand and cooperate with limb rehabilitation training due to factors such as severe aphasia
- Presence of severe visual field defects or visual impairments (e.g., hemianopsia, hemispatial neglect, etc.
- History of previous stroke
- A history of severe motor injury and/or surgical intervention of the affected upper limb, such as muscle tear, tendon rupture, rhabdomyolysis
- Life expectancy of less than 1 year due to the underlying disease
- Undergoing major surgery within the past 30 days or planning to undergo major surgery within the next 90 days
- Pregnant or lactating women
- History of drug or alcohol abuse, head trauma or central nervous system infection; current use of cognition-impairing medications such as psychoactive or sedative drugs
- With definite psychiatric and psychological disorders, such as depression, anxiety disorder, obsessive-compulsive disorder, schizophrenia, autism, chronic sleep disorder, consciousness disorder, etc.
- Having implanted electronic devices in the body that interfere with magnetic resonance imaging (MRI), such as cochlear implants, cardiac pacemakers/defibrillators, drug delivery pumps
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Related Publications (19)
Ward NS, Cohen LG. Mechanisms underlying recovery of motor function after stroke. Arch Neurol. 2004 Dec;61(12):1844-8. doi: 10.1001/archneur.61.12.1844.
PMID: 15596603BACKGROUNDMohapatra S, Harrington R, Chan E, Dromerick AW, Breceda EY, Harris-Love M. Role of contralesional hemisphere in paretic arm reaching in patients with severe arm paresis due to stroke: A preliminary report. Neurosci Lett. 2016 Mar 23;617:52-8. doi: 10.1016/j.neulet.2016.02.004. Epub 2016 Feb 9.
PMID: 26872851BACKGROUNDKaiser V, Daly I, Pichiorri F, Mattia D, Muller-Putz GR, Neuper C. Relationship between electrical brain responses to motor imagery and motor impairment in stroke. Stroke. 2012 Oct;43(10):2735-40. doi: 10.1161/STROKEAHA.112.665489. Epub 2012 Aug 14.
PMID: 22895995BACKGROUNDMa ZZ, Wu JJ, Cao Z, Hua XY, Zheng MX, Xing XX, Ma J, Xu JG. Motor imagery-based brain-computer interface rehabilitation programs enhance upper extremity performance and cortical activation in stroke patients. J Neuroeng Rehabil. 2024 May 29;21(1):91. doi: 10.1186/s12984-024-01387-w.
PMID: 38812014BACKGROUNDLiu X, Zhang W, Li W, Zhang S, Lv P, Yin Y. Effects of motor imagery based brain-computer interface on upper limb function and attention in stroke patients with hemiplegia: a randomized controlled trial. BMC Neurol. 2023 Mar 31;23(1):136. doi: 10.1186/s12883-023-03150-5.
PMID: 37003976BACKGROUNDKruse A, Suica Z, Taeymans J, Schuster-Amft C. Effect of brain-computer interface training based on non-invasive electroencephalography using motor imagery on functional recovery after stroke - a systematic review and meta-analysis. BMC Neurol. 2020 Oct 22;20(1):385. doi: 10.1186/s12883-020-01960-5.
PMID: 33092554BACKGROUNDMartini ML, Oermann EK, Opie NL, Panov F, Oxley T, Yaeger K. Sensor Modalities for Brain-Computer Interface Technology: A Comprehensive Literature Review. Neurosurgery. 2020 Feb 1;86(2):E108-E117. doi: 10.1093/neuros/nyz286.
PMID: 31361011BACKGROUNDColucci A, Vermehren M, Cavallo A, Angerhofer C, Peekhaus N, Zollo L, Kim WS, Paik NJ, Soekadar SR. Brain-Computer Interface-Controlled Exoskeletons in Clinical Neurorehabilitation: Ready or Not? Neurorehabil Neural Repair. 2022 Dec;36(12):747-756. doi: 10.1177/15459683221138751. Epub 2022 Nov 25.
PMID: 36426541BACKGROUNDWang A, Tian X, Jiang D, Yang C, Xu Q, Zhang Y, Zhao S, Zhang X, Jing J, Wei N, Wu Y, Lv W, Yang B, Zang D, Wang Y, Zhang Y, Wang Y, Meng X. Rehabilitation with brain-computer interface and upper limb motor function in ischemic stroke: A randomized controlled trial. Med. 2024 Jun 14;5(6):559-569.e4. doi: 10.1016/j.medj.2024.02.014. Epub 2024 Apr 19.
PMID: 38642555BACKGROUNDGBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
PMID: 38642570BACKGROUNDKim DH, Lee KD, Bulea TC, Park HS. Increasing motor cortex activation during grasping via novel robotic mirror hand therapy: a pilot fNIRS study. J Neuroeng Rehabil. 2022 Jan 24;19(1):8. doi: 10.1186/s12984-022-00988-7.
PMID: 35073933BACKGROUNDKurniawan S, Mubarak H, Sam N, Waluyo Y, Zainuddin AA, Mochtar AA. Enhancing Hand Motor Recovery Poststroke: A Comparative Study of Robotic vs Conventional Mirror Therapy. Arch Phys Med Rehabil. 2025 Aug;106(8):1183-1188. doi: 10.1016/j.apmr.2024.11.008. Epub 2024 Nov 29.
PMID: 39615826BACKGROUNDHe YZ, Huang ZM, Deng HY, Huang J, Wu JH, Wu JS. Feasibility, safety, and efficacy of task-oriented mirrored robotic training on upper-limb functions and activities of daily living in subacute poststroke patients: a pilot study. Eur J Phys Rehabil Med. 2023 Dec;59(6):660-668. doi: 10.23736/S1973-9087.23.08018-8. Epub 2023 Oct 23.
PMID: 37869761BACKGROUNDChen YW, Li KY, Lin CH, Hung PH, Lai HT, Wu CY. The effect of sequential combination of mirror therapy and robot-assisted therapy on motor function, daily function, and self-efficacy after stroke. Sci Rep. 2023 Oct 6;13(1):16841. doi: 10.1038/s41598-023-43981-3.
PMID: 37803096BACKGROUNDZhuang JY, Ding L, Shu BB, Chen D, Jia J. Associated Mirror Therapy Enhances Motor Recovery of the Upper Extremity and Daily Function after Stroke: A Randomized Control Study. Neural Plast. 2021 Sep 29;2021:7266263. doi: 10.1155/2021/7266263. eCollection 2021.
PMID: 34630560BACKGROUNDWinstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, Deruyter F, Eng JJ, Fisher B, Harvey RL, Lang CE, MacKay-Lyons M, Ottenbacher KJ, Pugh S, Reeves MJ, Richards LG, Stiers W, Zorowitz RD; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Jun;47(6):e98-e169. doi: 10.1161/STR.0000000000000098. Epub 2016 May 4.
PMID: 27145936BACKGROUNDAdham A, Bessaguet H, Struber L, Rimaud D, Ojardias E, Giraux P. Distinct and additive effects of visual and vibratory feedback for motor rehabilitation: an EEG study in healthy subjects. J Neuroeng Rehabil. 2024 Sep 12;21(1):158. doi: 10.1186/s12984-024-01453-3.
PMID: 39267092BACKGROUNDWang H, Xiong X, Zhang K, Wang X, Sun C, Zhu B, Xu Y, Fan M, Tong S, Guo X, Sun L. Motor network reorganization after motor imagery training in stroke patients with moderate to severe upper limb impairment. CNS Neurosci Ther. 2023 Feb;29(2):619-632. doi: 10.1111/cns.14065. Epub 2022 Dec 27.
PMID: 36575865BACKGROUNDLanghorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol. 2009 Aug;8(8):741-54. doi: 10.1016/S1474-4422(09)70150-4.
PMID: 19608100BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yong Cao, Pro.
Beijing Tiantan Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2026
First Posted
April 28, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
November 30, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
April 28, 2026
Record last verified: 2026-04